Sunitinib combined with pemetrexed and cisplatin: results of a phase I dose-escalation and pharmacokinetic study in patients with advanced solid malignancies, with an expanded cohort in non-small cell lung cancer and mesothelioma.
about
Latest developments in our understanding of the pathogenesis of mesothelioma and the design of targeted therapiesSpotlight on bevacizumab and its potential in the treatment of malignant pleural mesothelioma: the evidence to datePreliminary Safety, Pharmacokinetics, and Efficacy of Regorafenib, Cisplatin, and Pemetrexed in Patients With Advanced Nonsquamous Non-Small-Cell Lung Cancers.Targeted therapies in non-small cell lung carcinoma: what have we achieved so far?Evaluation of Safety and Efficacy of Salvage Therapy With Sunitinib, Docetaxel (Tyxan) and Cisplatinum Followed by Maintenance Vinorelbine for Unresectable/Metastatic Nonsmall Cell Lung Cancer: Stage 1 of a Simon 2 Stage Clinical Trial. [Corrected].The potential of sunitinib as a therapy in ovarian cancer.Searching for targets for the systemic therapy of mesothelioma.Sunitinib-induced sudden hearing loss.[Progress of platelet derived grow factor family in non-small cell lung cancer].[Efficacy and safety of albumin-bound paclitaxel in treating recurrent advanced non-small cell lung cancer].
P2860
Q28395597-A7C1DB2B-CB09-490D-BBA8-C41CCDFE39F8Q33563281-CE38FBC2-D49E-4708-B5E3-56BDCCEAC1CCQ36570837-5CA30425-3FC9-4791-88BE-074FE1F17F78Q36999705-23DD5459-CFF4-454B-BF87-6A1BC96D1851Q37624187-ADBDFC7C-15CD-445B-BE41-6ECE1F8D5F67Q38144166-80C8D690-8633-4A4C-B80B-43FB9AFD3590Q38365768-7C77B230-BF4B-4498-BFF1-37AAC2F01F3EQ50348948-8B0CAADA-C53C-4E02-866D-D6B1420429ECQ55464615-E04F4B09-DB7F-4E33-BDD3-D107BA06565DQ55498918-7C011E9D-AC45-4D3A-B055-781A45884312
P2860
Sunitinib combined with pemetrexed and cisplatin: results of a phase I dose-escalation and pharmacokinetic study in patients with advanced solid malignancies, with an expanded cohort in non-small cell lung cancer and mesothelioma.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Sunitinib combined with pemetr ...... lung cancer and mesothelioma.
@en
Sunitinib combined with pemetr ...... lung cancer and mesothelioma.
@nl
type
label
Sunitinib combined with pemetr ...... lung cancer and mesothelioma.
@en
Sunitinib combined with pemetr ...... lung cancer and mesothelioma.
@nl
prefLabel
Sunitinib combined with pemetr ...... lung cancer and mesothelioma.
@en
Sunitinib combined with pemetr ...... lung cancer and mesothelioma.
@nl
P2093
P2860
P1476
Sunitinib combined with pemetr ...... lung cancer and mesothelioma.
@en
P2093
Aron Thall
D Ross Camidge
Denis Soulières
Derek J Jonker
Laura Q Chow
Normand Blais
Richard C Chao
Robert C Doebele
Scott A Laurie
P2860
P2888
P304
P356
10.1007/S00280-012-2008-6
P577
2012-10-30T00:00:00Z